Microbicide Trials Network
The Microbicide Trials Network (MTN, 2006-2021) was a United States government-funded research organization working in the field of microbicides for sexually transmitted diseases.[1][2] The MTN focused on research into microbicides which would prevent HIV infection. The MTN was a member of HANC. After its closure, partner organization HIV Prevention Trials Network took control of its projects.[2]
Research
The MTN's notable research included various clinical trials.
The results of the CAPRISA 004 trial inspired the research of the MTN and the microbicide field.[3]
The Vaginal and Oral Interventions to Control the Epidemic (VOICE) found a vaginal gel containing an anti-HIV drug to be ineffective at preventing HIV transmission..[4]
The HOPE study tested dapivirine vaginal rings for HIV prevention in 1,456 study participants at 14 sites in Malawi, South Africa, Uganda and Zimbabwe.[5]
References
- ^ Hillier, Sharon (30 November 2021). "Thank you for these past 15 years". www.mtnstopshiv.org. Microbicide Trials Network.
- ^ a b Buhl, Larry (4 January 2021). "NIH Restructures HIV Clinical Trial Networks; AIDS Director Touts Milestones". thebodypro.com. HealthCentral.
- ^ Alcorn, Keith (19 July 2010). "Tenofovir-based microbicide gel reduces risk of infection for women by 39%". aidsmap.com. Aidsmap.
- ^ Cohen, Jon (28 November 2011). "Baffling Failure of Vaginal Gel Laced With Anti-HIV Drug - ScienceNOW". news.sciencemag.org. Archived from the original on 6 February 2012. Retrieved 6 March 2012.
- ^ "Most women use vaginal ring for HIV prevention in open-label study". National Institutes of Health (NIH). 23 July 2019.
External links
See what we do next...
OR
By submitting your email or phone number, you're giving mschf permission to send you email and/or recurring marketing texts. Data rates may apply. Text stop to cancel, help for help.
Success: You're subscribed now !